radionuclide therapy

You have access
Beyond ¹⁸F-FDG: Characterization of PET/CT and PET/MR Scanners for a Comprehensive Set of Positron Emitters of Growing Application—¹⁸F, ¹¹C, ⁸⁹Zr, ¹²⁴I, ⁶⁸Ga, and ⁹⁰Y
A. Therese Soderlund, Jasper Chaal, Gabriel Tjio, John J. Totman, Maurizio Conti and David W. Townsend

Journal of Nuclear Medicine August 1, 2015, 56 (8) 1285-1291; DOI: https://doi.org/10.2967/jnumed.115.156711
You have access
Intratherapeutic Biokinetic Measurements, Dosimetry Parameter Estimates, and Monitoring of Treatment Efficacy Using Cerenkov Luminescence Imaging in Preclinical Radionuclide Therapy
Oskar Vilhelmsson Timmermand, Thuy A. Tran, Sven-Erik Strand and Johan Axelsson

Journal of Nuclear Medicine March 1, 2015, 56 (3) 444-449; DOI: https://doi.org/10.2967/jnumed.114.148544
You have access
PMPA for Nephroprotection in PSMA-Targeted Radionuclide Therapy of Prostate Cancer
Clemens Kratochwil, Frederik L. Giesel, Karin Leotta, Matthias Eder, Torsten Hoppe-Tich, Hagop Youssoufian, Klaus Kopka, John W. Babich and Uwe Haberkorn

Journal of Nuclear Medicine February 1, 2015, 56 (2) 293-298; DOI: https://doi.org/10.2967/jnumed.114.147181
You have access
Promising Prospects for ⁴⁴Sc-/⁴⁷Sc-Based Theragnostics: Application of ⁴⁷Sc for Radionuclide Tumor Therapy in Mice
Cristina Müller, Maruta Bunka, Stephanie Haller, Ulli Köster, Viola Groehn, Peter Bernhardt, Nicholas van der Meulen, Andreas Türler and Roger Schibli

Journal of Nuclear Medicine October 1, 2014, 55 (10) 1658-1664; DOI: https://doi.org/10.2967/jnumed.114.141614
You have access
Evaluation of Cobalt-Labeled Octreotide Analogs for Molecular Imaging and Auger Electron–Based Radionuclide Therapy
Helge Thisgaard, Birgitte Brinkmann Olsen, Johan Hygum Dam, Peter Bollen, Jan Mollenhauer and Poul Flemming Høilund-Carlsen

Journal of Nuclear Medicine August 1, 2014, 55 (8) 1311-1316; DOI: https://doi.org/10.2967/jnumed.114.137182
You have access
A Compartmental Model of Mouse Thrombopoiesis and Erythropoiesis to Predict Bone Marrow Toxicity After Internal Irradiation
Nicolas Sas, Julie Rousseau, Frédérique Nguyen, Elise Bellec, Erik Larrsson, Sonia Becavin, Cecilia Hindorf, Jérôme Abadie, Nicolas Chouin and Jacques Barbet

Journal of Nuclear Medicine August 1, 2014, 55 (8) 1355-1360; DOI: https://doi.org/10.2967/jnumed.113.133330
You have access
Theranostics of Malignant Melanoma with ⁶⁴CuCl₂
Chunxia Qin, Hongguang Liu, Kai Chen, Xiang Hu, Xiaowei Ma, Xiaoli Lan, Yongxue Zhang and Zhen Cheng

Journal of Nuclear Medicine May 1, 2014, 55 (5) 812-817; DOI: https://doi.org/10.2967/jnumed.113.133850
You have access
Bone-Seeking Radiopharmaceuticals for Treatment of Osseous Metastases, Part 1: α Therapy with ²²³Ra-Dichloride
Neeta Pandit-Taskar, Steven M. Larson and Jorge A. Carrasquillo

Journal of Nuclear Medicine February 1, 2014, 55 (2) 268-274; DOI: https://doi.org/10.2967/jnumed.112.112482
You have access
Radiopharmaceutical Therapy of Patients with Metastasized Melanoma with the Melanin-Binding Benzamide ¹³¹I-BA52
Walter Mier, Clemens Kratochwil, Jessica C. Hassel, Frederik L. Giesel, Barbro Beijer, John W. Babich, Matthias Friebe, Michael Eisenhut, Alexander Enk and Uwe Haberkorn

Journal of Nuclear Medicine January 1, 2014, 55 (1) 9-14; DOI: https://doi.org/10.2967/jnumed.112.112789
You have access
Long-Term Outcome and Toxicity After Dose-Intensified Treatment with ¹³¹I-MIBG for Advanced Metastatic Carcinoid Tumors
Samer Ezziddin, Amir Sabet, Timur Logvinski, Khaled Alkawaldeh, Charlotte J. Yong-Hing, Hojjat Ahmadzadehfar, Frank Grünwald and Hans-Jürgen Biersack

Journal of Nuclear Medicine December 1, 2013, 54 (12) 2032-2038; DOI: https://doi.org/10.2967/jnumed.112.119313

Main menu

User menu

Search

radionuclide therapy

Pages